[Studies on the in vivo induction of differentiation of the erythroleukemia cells by the antigen-pulsed dendritic cells modified with GM-CSF gene].
To investigate the function and mechanism of dendritic cells in the immunotherapy for tumors. C57BL/6 mice inoculated with erythroleukemia cells were used as models. Inhibition or induction of tumor cell differentiation was observed by fluorescence-activated cell sorting (FACS) and transmission electron microscopy. After pulsed with FBL-3 antigen, the GM-CSF gene transfected dendritic cells inhibited the proliferation of the tumor cells. The expression of CD14 was increased and the expressions of MHC-II, B7-1, B7-2 and VCAM-1 were also up-regulated. Erythroleukemia cells in different differentiating stages were observed in tumor tissues. Under transmission electron microscope, the volumes of FBL-3 cells were reduced, the amount of lysosome and hetero-chromatin became plentiful, the nucleocytoplasmic ratio was decreased, and apoptosis was revealed in erythroleukemia cells. The CD8+ cells were increased in peripheral blood and tumor tissues. The antigen-pulsed dendritic cells modified with GM-CSF gene could induce in vivo the erythroleukemia cells to differentiate into monocytes.